Corrigendum: Evaluation of the SARS-CoV-2 Inactivation Efficacy Associated With Buffers From Three Kits Used on High-Throughput RNA Extraction Platforms

Corrigendum: Evaluation of the SARS-CoV-2 Inactivation Efficacy Associated With Buffers From Three Kits Used on High-Throughput RNA Extraction Platforms

[This corrects the article DOI: 10.3389/fcimb.2021.716436.].

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Frontiers in cellular and infection microbiology 2021-12, Vol.11, p.813442-813442
Hauptverfasser: Thom, Ruth E, Eastaugh, Lin S, O'Brien, Lyn M, Ulaeto, David O, Findlay, James S, Smither, Sophie J, Phelps, Amanda L, Stapleton, Helen L, Hamblin, Karleigh A, Weller, Simon A
Format: Artikel
Sprache:eng
Schlagworte:
biosafety
Cellular and Infection Microbiology
clinical diagnosis
high throughput
laboratory-acquired infection
PCR
SARS-CoV-2
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:[This corrects the article DOI: 10.3389/fcimb.2021.716436.].
ISSN:2235-2988
2235-2988
DOI:10.3389/fcimb.2021.813442